HARSHAVARDHAN DODDAPANENI to Drug Resistance, Neoplasm
This is a "connection" page, showing publications HARSHAVARDHAN DODDAPANENI has written about Drug Resistance, Neoplasm.
Connection Strength
0.282
-
Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers. Cell Rep Med. 2025 Jun 17; 6(6):102154.
Score: 0.158
-
Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer. Cancer Res. 2021 12 15; 81(24):6259-6272.
Score: 0.123